The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Tumour necrosis factor (TNF ) as a novel therapeutic target in symptomatic corticosteroid dependent asthma
Open accessAbstract
BACKGROUND: Tumour necrosis factor alpha (TNFalpha) is a major therapeutic target in a range of chronic inflammatory disorders characterised by a Th1 type immune response in which TNFalpha is generated in excess. By contrast, asthma is regarded as a Th2 type disorder, especially when associated with atopy. However, as asthma becomes more severe and chronic, it adopts additional characteristics including corticosteroid refractoriness and involvement of neutrophils suggestive of an altered inflammatory profile towards a Th1 type response, incriminating cytokines such as TNFalpha. METHODS: TNFalpha levels in bronchoalveolar lavage (BAL) fluid of 26 healthy controls, 42 subjects with mild asthma and 20 with severe asthma were measured by immunoassay, and TNFalpha gene expression was determined in endobronchial biopsy specimens from 14 patients with mild asthma and 14 with severe asthma. The cellular localisation of TNFalpha was assessed by immunohistochemistry. An open label uncontrolled clinical study was then undertaken in 17 subjects with severe asthma to evaluate the effect of 12 weeks of treatment with the soluble TNFalpha receptor-IgG1Fc fusion protein, etanercept. RESULTS: TNFalpha levels in BAL fluid, TNFalpha gene expression and TNFalpha immunoreative cells were increased in subjects with severe corticosteroid dependent asthma. Etanercept treatment was associated with improvement in asthma symptoms, lung function, and bronchial hyperresponsiveness. CONCLUSIONS: These findings may be of clinical significance in identifying TNFalpha as a new therapeutic target in subjects with severe asthma. The effects of anti-TNF treatment now require confirmation in placebo controlled studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Development and validation of a questionnaire to measure asthma control
Juniper, E. F., O′byrne, P. M., Guyatt, G. H., Ferrie, P. J., & King, D. R. (1999) · European Respiratory Journal · doi:10.1034/j.1399-3003.1999.14d29.x · Cited by 2,473
Weinblatt, M. E., Kremer, J. M., Bankhurst, A. D., Bulpitt, K. J., Fleischmann, R. M., Fox, R. I., Jackson, C. G., Lange, M., & Burge, D. J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901283400401 · Cited by 2,085
Standardization of bronchial inhalation challenge procedures
Chai, H., Farr, R. S., Froehlich, L. A., Mathison, D. A., McLean, J. A., Rosenthal, R. R., Sheffer, A. L., Spector, S. L., & Townley, R. G. (1975) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(75)90107-4 · Cited by 1,453
Kay, A. B. (2001) · New England Journal of Medicine · doi:10.1056/nejm200101043440106 · Cited by 1,368
Mast-Cell Infiltration of Airway Smooth Muscle in Asthma
Brightling, C. E., Bradding, P., Symon, F. A., Holgate, S. T., Wardlaw, A. J., & Pavord, I. D. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012705 · Cited by 1,241
Bradding, P., Roberts, J. A., Britten, K. M., Montefort, S., Djukanovic, R., Mueller, R., Heusser, C. H., Howarth, P. H., & Holgate, S. T. (1994) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.10.5.8179909 · Cited by 830
Self-citationThe ENFUMOSA Study Group (2003) · European Respiratory Journal · doi:10.1183/09031936.03.00261903 · Cited by 759
Cytokines in symptomatic asthma airways
Broide, D. H., Lotz, M., Cuomo, A. J., Coburn, D. A., Federman, E. C., & Wasserman, S. I. (1992) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(92)90218-q · Cited by 736
Van den Brande, J. M. H., Braat, H., van den Brink, G. R., Versteeg, H. H., Bauer, C. A., Hoedemaeker, I., van Montfrans, C., Hommes, D. W., Peppelenbosch, M. P., & van Deventer, S. J. H. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00382-2 · Cited by 723
TNF defined as a therapeutic target for rheumatoid arthritis and other autoimmune diseases
Feldmann, M., & Maini, R. N. (2003) · Nature Medicine · doi:10.1038/nm939 · Cited by 584
Tumor necrosis factor is chemotactic for monocytes and polymorphonuclear leukocytes.
Ming, W. J., Bersani, L., & Mantovani, A. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.138.5.1469 · Cited by 522
Thomas, P. S., Yates, D. H., & Barnes, P. J. (1995) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.152.1.7599866 · Cited by 360
Factors Associated with Persistent Airflow Limitation in Severe Asthma
ten BRINKE, A., ZWINDERMAN, A. H., STERK, P. J., RABE, K. F., & BEL, E. H. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.5.2011026 · Cited by 360
Ulbrich, H., Eriksson, E. E., & Lindbom, L. (2003) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2003.10.004 · Cited by 354
Tumour necrosis factor‐α: The role of this multifunctional cytokine in asthma
Thomas, P. S. (2001) · Immunology & Cell Biology · doi:10.1046/j.1440-1711.2001.00980.x · Cited by 314
Asthma severity and medical resource utilisation
Antonicelli, L., Bucca, C., Neri, M., De Benedetto, F., Sabbatani, P., Bonifazi, F., Eichler, H., Zhang, Q., & Yin, D. D. (2004) · European Respiratory Journal · doi:10.1183/09031936.04.00004904 · Cited by 290
Tumor Necrosis Factor Causes Bronchial Hyperresponsiveness in Rats
Kips, J. C., Tavernier, J., & Pauwels, R. A. (1992) · American Review of Respiratory Disease · doi:10.1164/ajrccm/145.2_pt_1.332 · Cited by 284
TILLIE-LEBLOND, I., PUGIN, J., MARQUETTE, C.-H., LAMBLIN, C., SAULNIER, F., BRICHET, A., WALLAERT, B., TONNEL, A.-B., & GOSSET, P. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.159.2.9805115 · Cited by 259
Britten, K. M., Howarth, P. H., & Roche, W. R. (1993) · Biotechnic & Histochemistry · doi:10.3109/10520299309105629 · Cited by 231
Self-citationWedzicha, J. A. (2003) · Thorax · doi:10.1136/thorax.58.1.1 · Cited by 227
Pathophysiology of severe asthma
Busse, W. W., Banks-Schlegel, S., & Wenzel, S. E. (2000) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2000.111307 · Cited by 218
Tumor necrosis factor inhibitors: Clinical implications of their different immunogenicity profiles
Anderson, P. J. (2005) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2005.01.005 · Cited by 202
O'Byrne, P. M., & Inman, M. D. (2003) · Chest · doi:10.1378/chest.123.3_suppl.411s · Cited by 201
British guidelines on the management of asthma.
Clancy, K. X. (2004) · PubMed · Cited by 189
Effects of inhaled tumour necrosis factor alpha in subjects with mild asthma
Thomas, P. S. (2002) · Thorax · doi:10.1136/thorax.57.9.774 · Cited by 139
Pizzichini, E., Pizzichini, M. M. M., Kidney, J., Efthimiadis, A., Hussack, P., Popov, T. A., Cox, G., Dolovich, J., O’Byrne, P. M., & Hargreave, F. E. (1998) · European Respiratory Journal · doi:10.1183/09031936.98.11040828 · Cited by 109
Wa, L. K., Mansur, Britton, Williams, Pavord, I. D., Richards, Campbell, Morton, Holgate, & Morrison (1999) · Clinical & Experimental Allergy · doi:10.1046/j.1365-2222.1999.00638.x · Cited by 102
Culy, C. R., & Keating, G. M. (2002) · Drugs · doi:10.2165/00003495-200262170-00013 · Cited by 89
Association between TNFA Polymorphism and the Development of Asthma in the Japanese Population
Noguchi, E., Yokouchi, Y., Shibasaki, M., Inudou, M., Nakahara, S., Nogami, T., Kamioka, M., Yamakawa‐Kobayashi, K., Ichikawa, K., Matsui, A., et al. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2110052 · Cited by 79
Peck, R. N., Fitzgerald, D. W., Liautaud, B., Deschamps, M., Verdier, R.-I., Beaulieu, M. E., GrandPierre, R., Joseph, P., Sévère, P., Noël, F., et al. (2003) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200308010-00007 · Cited by 67
Modulation of allergic inflammation in mice deficient in TNF receptors
Rudmann, D. G., Moore, M. W., Tepper, J. S., Aldrich, M. C., Pfeiffer, J. W., HogenEsch, H., & Tumas, D. B. (2000) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.2000.279.6.l1047 · Cited by 60
Koranteng, R. D., Swindle, E. J., Davis, B. J., Dearman, R. J., Kimber, I., Flanagan, B., & Coleman, J. W. (2004) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2004.02510.x · Cited by 42
Cited by
TNF-mediated inflammatory disease
Bradley, Jr. (2008) · The Journal of Pathology · doi:10.1002/path.2287 · Cited by 2,094
Tumor necrosis factor antagonist mechanisms of action: A comprehensive review
Tracey, D., Klareskog, L., Sasso, E. H., Salfeld, J. G., & Tak, P. P. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.10.001 · Cited by 1,628
Asthma: defining of the persistent adult phenotypes
Wenzel, S. E. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69290-8 · Cited by 1,043
Evidence of a Role of Tumor Necrosis Factor α in Refractory Asthma
Berry, M. A., Hargadon, B., Shelley, M., Parker, D., Shaw, D. E., Green, R. H., Bradding, P., Brightling, C. E., Wardlaw, A. J., & Pavord, I. D. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa050580 · Cited by 826
HOLGATE, S. T. (2008) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2008.02971.x · Cited by 809
Metadata
- Authors
- Howarth, P. H.
- Venue
- Thorax
- Publisher
- BMJ
- Published
- 2005-12-01
- Volume
- 60
- Issue
- 12
- Pages
- 1012-1018
- ISSN
- 0040-6376 (ISSN-L)
- OpenAlex
- W2124657474
- Cited by
- 495
- References
- 32
- FWCI
- 31.93
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.